CooperSurgical, Inc.

Form 483 issued February 1, 2024 · North Tonawanda, New York

Inspection
Jan 29 – Feb 1, 2024
Observations
2
Pages
4
FEI number
1316626

In short: On February 1, 2024, FDA issued a Form 483 with 2 observations to CooperSurgical, Inc. in North Tonawanda, New York (FEI 1316626) after an inspection that ran Jan 29 – Feb 1, 2024. The investigator was Matthew D. Schnittker. Most observations concern cAPA and production & process controls; the most-cited regulation is 21 CFR 820.100 (corrective and preventive action).

At a glance

CAPA and production & process controls account for 2 of 2 observations.

CAPA1
Production & process controls1

Most cited: 21 CFR 820.100 (1×) · 820.75 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures for corrective and preventive action have…

  2. 02

    Manufacturer A process whose results cannot be fully verified by subsequent inspection and test has not…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at CooperSurgical, Inc.?

FDA listed 2 observations on this Form 483, mostly about cAPA and production & process controls. The most-cited regulation is 21 CFR 820.100 (corrective and preventive action). The opening words of each observation are shown on this page.

Who inspected CooperSurgical, Inc.?

Matthew D. Schnittker is named on this Form 483, for the inspection of Jan 29 – Feb 1, 2024. Each investigator has a profile showing what they cite most.

When was CooperSurgical, Inc. inspected by FDA?

The inspection ran Jan 29 – Feb 1, 2024, and the Form 483 is dated February 1, 2024.

How do I get the full Form 483 for CooperSurgical, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free